type here...
type here...
START FREE TRIAL

Ishan Majumdar

This “Broken” Biotech Just Forced Wall Street To Blink

M&A Ishan Majumdar -
Apellis Pharmaceuticals (NASDAQ:APLS) did not suddenly discover a miracle on Tuesday. What changed was the price investors were willing...

Tesla Is Quietly Killing Its Own Cars—& What Comes Next Could Be MUCH BIGGER

Automobiles Ishan Majumdar -
For years, most investors have approached Tesla as an electric-vehicle company with some extra optionality around software. That framing...

This Medical Device Stock Just Got CRUSHED On One Hidden Number; Did Wall Street Misread It?

Healthcare Ishan Majumdar -
Boston Scientific (NYSE:BSX) spent the weekend putting forward what looked, at first glance, like a clinically solid case for...

This Widely Held “Defensive” Stock Is Now Tied To A Large Scale Merger

M&A Ishan Majumdar -
For years, McCormick (NYSE:MKC) has been framed as one of those dependable staples names investors can tuck away and...

A First-In-Class Biotech Is Still Trading Below Its Strategic Value Today

Healthcare Ishan Majumdar -
A mid-cap biotech with the first approved therapy in a large, long-underfunded liver disease category is not supposed to...

Microsoft: The AI Golden Child Is CRACKING, & Copilot Is The Real Problem!

Technology & AI Ishan Majumdar -
For a long time, Microsoft looked like the safest and cleanest way to play the AI boom. It had...
spot_imgspot_img

AI Is Replacing Humans Inside Meta—Starting With Zuckerberg Himself!

Technology & AI Ishan Majumdar -
There are AI stories, and then there are moments that feel like a shift in how work itself is...

Ondas & AeroVironment: One Drone Stock Sells The Dream, The Other Sells The Proof

Technology & AI Ishan Majumdar -
If you have looked at drone stocks lately, you have probably noticed that Ondas (NASDAQ:ONDS) and AeroVironment (NASDAQ:AVAV) can...

The AI Boom Is Actually An Energy Story — & NVIDIA Knows It!

Technology & AI Ishan Majumdar -
For the past two years, the artificial intelligence boom has been framed around one constraint: chips. The dominant narrative...

The $180 Oil Scenario: What A Prolonged Oil Shock Could Mean For Chevron Vs. Exxon

Energy Ishan Majumdar -
The latest oil move has been driven less by ordinary commodity tightening and more by geopolitical repricing. Brent crude...

Uber & Rivian Aren’t Just Building Robotaxis—They’re Building BUZZ!

Transportation Ishan Majumdar -
Uber (NYSE:UBER) is not building the car, the sensor stack, or the factory line. Yet it keeps showing up...

Is Align A Classic Activist Win, Or A HARDER Consumer Story?

Healthcare Ishan Majumdar -
Align Technology (NASDAQ:ALGN) has become a useful test case for a very modern market question. What happens when Wall...
Load more

Baptista Research is a financial research house focused on the U.S. markets. We cover the top-listed U.S. companies with most of our focus on technology, consumer goods and services, automobiles, industrials, oil and gas, pharma, and healthcare. Our research has served more than 3000 institutional investors including mutual funds, hedge funds, banks, family offices, and various buy-side firms.

Company

Headlines

This “Broken” Biotech Just Forced Wall Street To Blink

0
Apellis Pharmaceuticals (NASDAQ:APLS) did not suddenly discover a miracle...

Tesla Is Quietly Killing Its Own Cars—& What Comes Next Could Be MUCH BIGGER

0
For years, most investors have approached Tesla as an...

This Medical Device Stock Just Got CRUSHED On One Hidden Number; Did Wall Street Misread It?

0
Boston Scientific (NYSE:BSX) spent the weekend putting forward what...

This Widely Held “Defensive” Stock Is Now Tied To A Large Scale Merger

0
For years, McCormick (NYSE:MKC) has been framed as one...

Newsletter

Get important news delivered directly to your inbox and stay connected!

Copyright © 2026 Baptista Research. All rights reserved.